Longer interval between COVID-19 vaccines generates up to nine times as many antibodies
WHO strongly recommends antiviral drug for patients with non-severe COVID-19
21 April 2022Stricter COVID measures associated with negative mental health effects, lower opinion of government’s pandemic response
22 April 2022Longer interval between COVID-19 vaccines generates up to nine times as many antibodies
New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study is available as a preprint.
